BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024

Shares 32,630 Value ($000) $166 Avg Close $5.62 Range $4.82 - $7.75

Q4 2023

Shares 60,159 Value ($000) $360 Avg Close $5.79 Range $4.83 - $7.06

Q3 2023

Shares 241,820 Value ($000) $1,712 Avg Close $7.18 Range $6.62 - $7.95

Q2 2023

Shares 232,463 Value ($000) $1,637 Avg Close $8.02 Range $6.87 - $9.07

Q1 2023

Shares 225,764 Value ($000) $1,883 Avg Close $9.63 Range $7.82 - $12.08

Q3 2022

Shares 216,327 Value ($000) $2,726,000 Avg Close $12.87 Range $10.33 - $15.43

Q2 2022

Shares 236,327 Value ($000) $2,500,000 Avg Close $10.32 Range $7.61 - $18.00

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2024	32,630	$166	$5.62	$4.82 - $7.75
Q4 2023	60,159	$360	$5.79	$4.83 - $7.06
Q3 2023	241,820	$1,712	$7.18	$6.62 - $7.95
Q2 2023	232,463	$1,637	$8.02	$6.87 - $9.07
Q1 2023	225,764	$1,883	$9.63	$7.82 - $12.08
Q3 2022	216,327	$2,726,000	$12.87	$10.33 - $15.43
Q2 2022	236,327	$2,500,000	$10.32	$7.61 - $18.00